Kelly Miller

Company: Quanterix

Job title: Director of Strategic Collaborations

Seminars:

Ultrasensitive Biomarkers for Neurodegenerative Disease: Clinical and Diagnostic Advances 11:15 am

New translational ultrasensitive biomarkers that can help define and categorize  neurodegenerative diseases. Use in clinical trials and Dx applications Performance characteristics of Simoa-based LDT testing programs utilizing ultrasensitive neurodegeneration biomarkers Analytical and clinical sensitivity of Alzheimer’s disease blood-based biomarkers (pTau217 and Multimarker panels)Read more

day: Conference Day One